[HTML][HTML] Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States
R Li, H Liu, CK Fairley, Z Zou, L Xie, X Li… - International Journal of …, 2022 - Elsevier
Objectives To evaluate the cost-effectiveness of a booster strategy in the United States.
Methods We developed a decision-analytic Markov model of COVID-19 to evaluate the cost …
Methods We developed a decision-analytic Markov model of COVID-19 to evaluate the cost …
[HTML][HTML] Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States
R Li, H Liu, CK Fairley, Z Zou, L Xie, X Li… - … Journal of Infectious …, 2022 - ncbi.nlm.nih.gov
Methods We developed a decision-analytic Markov model of COVID-19 to evaluate the cost-
effectiveness of a booster strategy of the Pfizer-BioNTech BNT162b2 (administered 6 …
effectiveness of a booster strategy of the Pfizer-BioNTech BNT162b2 (administered 6 …
Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States.
R Li, H Liu, CK Fairley, Z Zou, L Xie, X Li, M Shen, Y Li… - 2022 - cabidigitallibrary.org
Objectives: To evaluate the cost-effectiveness of a booster strategy in the United States.
Methods: We developed a decision-analytic Markov model of COVID-19 to evaluate the cost …
Methods: We developed a decision-analytic Markov model of COVID-19 to evaluate the cost …
Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States
R Li, H Liu, CK Fairley, Z Zou, L Xie… - … publication of the …, 2022 - pubmed.ncbi.nlm.nih.gov
Objectives To evaluate the cost-effectiveness of a booster strategy in the United States.
Methods We developed a decision-analytic Markov model of COVID-19 to evaluate the cost …
Methods We developed a decision-analytic Markov model of COVID-19 to evaluate the cost …
Cost-Effectiveness Analysis of BNT162b2 COVID-19 Booster Vaccination in the United States
R Li, H Liu, CK Fairley, Z Zou, L Xie, X Li… - Available at SSRN … - papers.ssrn.com
Background: Over 86% of older adults aged≥ 65 years are fully vaccinated against SARS-
COV-2 in the United States (US). Waning protection of the existing vaccines promotes the …
COV-2 in the United States (US). Waning protection of the existing vaccines promotes the …
Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States
R Li, H Liu, CK Fairley, Z Zou, L Xie, X Li, M Shen, Y Li… - medRxiv, 2021 - medrxiv.org
Background Over 86% of older adults aged≥ 65 years are fully vaccinated against SARS-
COV-2 in the United States (US). Waning protection of the existing vaccines promotes the …
COV-2 in the United States (US). Waning protection of the existing vaccines promotes the …
[PDF][PDF] Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States
scholar.archive.org
Background: Over 86% of older adults aged≥ 65 years are fully vaccinated against SARS-
COV-2 in the United States (US). Waning protection of the existing vaccines promotes the …
COV-2 in the United States (US). Waning protection of the existing vaccines promotes the …
Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States.
R Li, H Liu, CK Fairley, Z Zou, L Xie, X Li… - … Journal of Infectious …, 2022 - europepmc.org
Methods We developed a decision-analytic Markov model of COVID-19 to evaluate the cost-
effectiveness of a booster strategy of the Pfizer-BioNTech BNT162b2 (administered 6 …
effectiveness of a booster strategy of the Pfizer-BioNTech BNT162b2 (administered 6 …
Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States
R Li, H Liu, CK Fairley, Z Zou, L Xie, X Li, M Shen, Y Li… - 2021 - pesquisa.bvsalud.org
Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States |
PREPRINT-MEDRXIV loading 1 2 3 +A A -A 3.Cost-effectiveness analysis of BNT162b2 …
PREPRINT-MEDRXIV loading 1 2 3 +A A -A 3.Cost-effectiveness analysis of BNT162b2 …
Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States
R Li, H Liu, CK Fairley, Z Zou, L Xie… - … Journal of Infectious …, 2022 - research.monash.edu
Objectives: To evaluate the cost-effectiveness of a booster strategy in the United States.
Methods: We developed a decision-analytic Markov model of COVID-19 to evaluate the cost …
Methods: We developed a decision-analytic Markov model of COVID-19 to evaluate the cost …